Tiparvovec is a gene therapy drug that has been used to treat a rare genetic disorder known as lipoprotein lipase deficiency. This drug is also known as Glybera and is made up of viral vectors that deliver functional copies of the LPL gene into the fatty tissues of the patient. While there are no strict synonyms for the word "Tiparvovec", it is often referred to as a gene therapy drug or LPL gene therapy. Gene therapy is a relatively new field of medicine that involves the introduction of healthy genes into a patient's cells to treat or cure a disease. Other potential synonyms for Tiparvovec could include "LPL gene delivery system" or "gene replacement therapy".